Mevion Medical Systems

The company works with customers to configure image-guidance and patient-positioning systems for each radiation therapy department.

The MEVION S250 uses a gantry-mounted proton accelerator and delivers a stable, uniform proton beam. It has treated patients at multiple sites in the United States since 2013.

The MEVION S250i uses HYPERSCAN pencil beam scanning for IMPT. Its Adaptive Aperture automatically tailors beam characteristics to match the tumor.

The MEVION S250mx is a proton therapy system available in two-, three-, or four-room configurations, with independent treatment rooms.

MEVION-IONOSPHERE publishes proton therapy news, insights, and educational content.

Mevion Medical Systems offers investigator-initiated research funding for projects and manufactures compact proton therapy systems for cancer treatment.

The page provides resources for patients, including FAQs explaining proton therapy and how it differs from conventional photon radiation therapy.

The page provides clinical evidence about proton therapy, educational materials for patients and providers, and information about the MEVION S250 Series.

The Mevion Medical Systems newsroom provides high-resolution images for editorial use; the images are copyrighted by Mevion Medical Systems, Inc.

NEWSROOM PRESS RELEASES View All Events View All In the News View All

The page lists regional contact details for Mevion Medical Systems, including the Americas, EMEA, Asia-Pacific, and China.

Rönesans selected MEVION S250-FIT for proton therapy in Türkiye; Auburn installed a superconducting proton accelerator; Mevion reported the system’s first clinical treatment; Mevion Medical Systems partnered with Tam Anh General Hospital to bring proton therapy to Vietnam.

Mevion Medical Systems' privacy policy describes how the company collects, processes, retains, and discloses personal data when providing services linked to the policy.

The Mevion Medical Systems website provides information about the company and its products for health care professionals, patients, and industry audiences.